Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Neogen's Food Safety Business Thrives on Ergot Alkaloids Test

The newly-developed Reveal Q+ MAX test is likely to fortify Neogen's (NEOG) presence in the global food allergen testing market.

NUVA : 75.76 (+2.59%)
RMD : 153.02 (+0.51%)
NEOG : 68.02 (-1.62%)
HAE : 116.84 (-0.28%)
Bruker Launches Luxendo TruLive3D Imager, Expands NANO Arm (Revised)

Bruker's (BRKR) latest Luxendo TruLive3D Imager revolutionizes cell culture live imaging in natural environments.

BRKR : 48.72 (-1.73%)
HAE : 116.84 (-0.28%)
RMD : 153.02 (+0.51%)
EYE : 31.67 (-0.28%)
Intersect ENT (XENT) Grows on Innovation Despite Cost Woes

The latest offering in Intersect ENT's (XENT) SINUVA portfolio is specific J code - J7401.

XENT : 21.39 (-0.42%)
NUVA : 75.76 (+2.59%)
RMD : 153.02 (+0.51%)
HAE : 116.84 (-0.28%)
Walgreens Extends Deal to Form GPO With Retail Giant Kroger

Per Walgreens (WBA), its alliance with Kroger will lead to supply chain efficiencies, capitalizing on their joint resources.

RMD : 153.02 (+0.51%)
HAE : 116.84 (-0.28%)
NUVA : 75.76 (+2.59%)
WBA : 57.91 (-1.14%)
Here's Why You Should Hold on to Quest Diagnostics Stock Now

Investors can retain Quest Diagnostics (DGX) stock in their portfolio, thanks to solid prospects.

HAE : 116.84 (-0.28%)
NUVA : 75.76 (+2.59%)
RMD : 153.02 (+0.51%)
DGX : 105.08 (-0.23%)
Here's Why You Should Add Omnicell to Your Portfolio Now

Investor confidence in Omnicell (OMCL) is at a high, thanks to solid prospects.

OMCL : 79.94 (-1.21%)
HAE : 116.84 (-0.28%)
RMD : 153.02 (+0.51%)
NUVA : 75.76 (+2.59%)
Haemonetics Opens New Corporate Headquarters In Downtown Boston

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today opened its new global headquarters...

HAE : 116.84 (-0.28%)
CVS Health Rides on Aetna Prospects, Strong Selling Season

CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.

RMD : 153.02 (+0.51%)
HAE : 116.84 (-0.28%)
CVS : 73.93 (-0.44%)
EYE : 31.67 (-0.28%)
Omnicell-Huron Sign a Pact for Outcome-Based Expert Services

Omnicell (OMCL) partners Huron to provide customers with committed expertise.

OMCL : 79.94 (-1.21%)
RMD : 153.02 (+0.51%)
HAE : 116.84 (-0.28%)
EYE : 31.67 (-0.28%)
Bruker Launches Luxendo TruLive3D Imager in Mass Spectrometry

Bruker's (BRKR) Luxendo TruLive3D Imager revolutionizes cell culture live imaging in natural environment.

BRKR : 48.72 (-1.73%)
RMD : 153.02 (+0.51%)
HAE : 116.84 (-0.28%)
EYE : 31.67 (-0.28%)
Globus Medical Hits 52-Week High: What's Driving the Stock?

Globus Medical (GMED) is optimistic about sustaining its growth momentum on recent positive developments.

GMED : 57.85 (+0.10%)
RMD : 153.02 (+0.51%)
HAE : 116.84 (-0.28%)
EYE : 31.67 (-0.28%)
Omnicell (OMCL) Partners With Kit Check to Offer Bluesight

This partnership will offer Omnicell (OMCL) the state-of-the art technology and medication intelligence needed to ensure accurate delivery of drugs to the right patients.

OMCL : 79.94 (-1.21%)
NUVA : 75.76 (+2.59%)
RMD : 153.02 (+0.51%)
HAE : 116.84 (-0.28%)
NUVA vs. HAE: Which Stock Should Value Investors Buy Now?

NUVA vs. HAE: Which Stock Is the Better Value Option?

NUVA : 75.76 (+2.59%)
HAE : 116.84 (-0.28%)
Edwards Lifesciences (EW) Plans Strong Long-Term TAVR Growth

Within TAVR, Edwards (EW) expects global TAVR opportunity to exceed $7 billion by 2024.

NUVA : 75.76 (+2.59%)
EW : 231.49 (+0.34%)
HAE : 116.84 (-0.28%)
RMD : 153.02 (+0.51%)
Amedisys (AMED) Benefits From Home Health and Personal Care

Amedisys' (AMED) impressive performance in the newly-unveiled Personal Care segment is appreciative.

RMD : 153.02 (+0.51%)
HAE : 116.84 (-0.28%)
NUVA : 75.76 (+2.59%)
AMED : 161.64 (-1.08%)
Thermo Fisher (TMO) at a 52-Week High: What's Driving It?

Thermo Fisher (TMO) gains from solid overseas expansion and acquisitions.

TMO : 319.21 (-0.05%)
HAE : 116.84 (-0.28%)
NUVA : 75.76 (+2.59%)
RMD : 153.02 (+0.51%)
NuVasive Hits New 52-Week High: What's Driving the Stock?

NuVasive (NUVA) is optimistic about maintaining the momentum on several positive developments.

HAE : 116.84 (-0.28%)
RMD : 153.02 (+0.51%)
NUVA : 75.76 (+2.59%)
EYE : 31.67 (-0.28%)
TransMedics' OCS Technology Sees Success in Heart Transplant

TransMedics (TMDX) successfully completes heart transplants from DCD donors, using its OCS technology.

HAE : 116.84 (-0.28%)
RMD : 153.02 (+0.51%)
EYE : 31.67 (-0.28%)
TMDX : 18.42 (+4.78%)
NuVasive (NUVA) Hits 52-Week High, Can the Run Continue?

NuVasive (NUVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

NUVA : 75.76 (+2.59%)
EW : 231.49 (+0.34%)
HAE : 116.84 (-0.28%)
NURO : 4.31 (-2.71%)
Omnicell to Feature Upgrades in Medication Management at ASHP

Omnicell (OMCL) to showcase innovations in medication management solution portfolio to minimize human errors by care providers.

OMCL : 79.94 (-1.21%)
HAE : 116.84 (-0.28%)
RMD : 153.02 (+0.51%)
EYE : 31.67 (-0.28%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.56 , AIZ -0.37 , SBAC +4.57 , SO +0.13 , WELL -0.95
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar